Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Cumberland Pharmaceuticals ROE 2010-2023 | CPIX

Current and historical return on equity (ROE) values for Cumberland Pharmaceuticals (CPIX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Cumberland Pharmaceuticals ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $-0.01B $0.03B -17.39%
2023-09-30 $-0.00B $0.04B -5.52%
2023-06-30 $-0.00B $0.04B -2.72%
2023-03-31 $-0.00B $0.04B -8.05%
2022-12-31 $-0.00B $0.04B -10.39%
2022-09-30 $-0.01B $0.04B -14.91%
2022-06-30 $-0.01B $0.04B -16.47%
2022-03-31 $-0.01B $0.04B -11.17%
2021-12-31 $-0.00B $0.04B -8.65%
2021-09-30 $-0.00B $0.05B -2.12%
2021-06-30 $0.00B $0.05B 0.00%
2021-03-31 $-0.00B $0.05B -4.21%
2020-12-31 $-0.00B $0.05B -6.22%
2020-09-30 $-0.00B $0.05B -6.09%
2020-06-30 $-0.01B $0.05B -9.95%
2020-03-31 $-0.01B $0.05B -9.66%
2019-12-31 $-0.00B $0.05B -7.55%
2019-09-30 $-0.01B $0.05B -9.22%
2019-06-30 $-0.01B $0.05B -8.97%
2019-03-31 $-0.01B $0.06B -8.73%
2018-12-31 $-0.01B $0.06B -11.91%
2018-09-30 $-0.01B $0.06B -9.88%
2018-06-30 $-0.01B $0.06B -8.00%
2018-03-31 $-0.01B $0.06B -14.06%
2017-12-31 $-0.01B $0.06B -11.99%
2017-09-30 $-0.01B $0.07B -11.59%
2017-06-30 $-0.01B $0.07B -9.82%
2017-03-31 $-0.00B $0.07B -2.73%
2016-12-31 $-0.00B $0.07B -1.35%
2016-09-30 $0.00B $0.07B 0.00%
2016-06-30 $0.00B $0.07B 0.00%
2016-03-31 $0.00B $0.08B 0.00%
2015-12-31 $0.00B $0.08B 0.00%
2015-09-30 $0.00B $0.08B 1.26%
2015-06-30 $0.00B $0.08B 2.50%
2015-03-31 $0.00B $0.08B 3.73%
2014-12-31 $0.00B $0.08B 3.73%
2014-09-30 $0.00B $0.08B 0.00%
2014-06-30 $-0.00B $0.08B -2.50%
2014-03-31 $-0.00B $0.08B -4.97%
2013-12-31 $-0.00B $0.08B -3.66%
2013-09-30 $0.00B $0.08B 1.19%
2013-06-30 $0.00B $0.08B 4.75%
2013-03-31 $0.01B $0.09B 8.31%
2012-12-31 $0.01B $0.09B 7.19%
2012-09-30 $0.01B $0.08B 6.04%
2012-06-30 $0.01B $0.08B 6.04%
2012-03-31 $0.01B $0.08B 6.08%
2011-12-31 $0.01B $0.08B 7.38%
2011-09-30 $0.01B $0.08B 7.50%
2011-06-30 $0.01B $0.08B 6.41%
2011-03-31 $0.00B $0.08B 3.95%
2010-12-31 $0.00B $0.08B 2.67%
2010-09-30 $0.00B $0.08B 1.36%
2010-06-30 $0.00B $0.07B 1.38%
2010-03-31 $0.00B $0.07B 1.69%
2009-12-31 $0.00B $0.07B 4.91%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.023B $0.040B
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.564B 27.36
Chugai Pharmaceutical (CHGCY) Japan $54.745B 23.77
Takeda Pharmaceutical (TAK) Japan $42.282B 6.85
Merck (MKGAF) Germany $20.162B 19.02
Astellas Pharma (ALPMY) Japan $17.246B 24.44
Sandoz Group AG (SDZNY) Switzerland $14.663B 0.00
Shionogi (SGIOY) Japan $14.423B 12.48
Neurocrine Biosciences (NBIX) United States $13.300B 55.23
United Therapeutics (UTHR) United States $11.015B 11.80
Catalent (CTLT) United States $10.144B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.644B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.856B 6.95
Revolution Medicines (RVMD) United States $6.000B 0.00
Ionis Pharmaceuticals (IONS) United States $5.986B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.248B 0.00
Alpine Immune Sciences (ALPN) United States $4.233B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.023B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.964B 0.00
Evotec AG (EVO) Germany $2.608B 0.00
Indivior (INDV) United States $2.556B 11.89
Summit Therapeutics (SMMT) United States $2.449B 0.00
Corcept Therapeutics (CORT) United States $2.321B 23.47
Dyne Therapeutics (DYN) United States $2.143B 0.00
PTC Therapeutics (PTCT) United States $1.990B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.809B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.806B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.783B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.782B 18.42
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.649B 9.76
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.80
Avadel Pharmaceuticals (AVDL) Ireland $1.567B 0.00
Ardelyx (ARDX) United States $1.515B 0.00
4D Molecular Therapeutics (FDMT) United States $1.350B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.262B 11.85
Soleno Therapeutics (SLNO) United States $1.219B 0.00
Pacira BioSciences (PCRX) United States $1.214B 12.08
Collegium Pharmaceutical (COLL) United States $1.136B 6.99
Xencor (XNCR) United States $1.113B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.003B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.909B 0.00
Cronos Group (CRON) Canada $0.902B 0.00
Cassava Sciences (SAVA) United States $0.887B 0.00
USANA Health Sciences (USNA) United States $0.851B 13.40
Enliven Therapeutics (ELVN) United States $0.825B 0.00
ARS Pharmaceuticals (SPRY) United States $0.792B 0.00
Ocular Therapeutix (OCUL) United States $0.785B 0.00
Relay Therapeutics (RLAY) United States $0.781B 0.00
Sage Therapeutics (SAGE) United States $0.775B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.730B 0.00
Silence Therapeutics (SLN) United Kingdom $0.673B 0.00
Savara (SVRA) United States $0.649B 0.00
ProKidney (PROK) United States $0.624B 0.00
Lyell Immunopharma (LYEL) United States $0.612B 0.00
Siga Technologies (SIGA) United States $0.594B 8.79
Verve Therapeutics (VERV) United States $0.578B 0.00
Korro Bio (KRRO) United States $0.549B 0.00
OmniAb (OABI) United States $0.548B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.539B 0.00
Altimmune (ALT) United States $0.530B 0.00
Exscientia (EXAI) United Kingdom $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.483B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.459B 0.00
Lexeo Therapeutics (LXEO) United States $0.417B 0.00
Larimar Therapeutics (LRMR) United States $0.408B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.392B 74.25
Heron Therapeutics (HRTX) United States $0.389B 0.00
Harrow (HROW) United States $0.375B 0.00
Nature's Sunshine Products (NATR) United States $0.365B 20.43
Esperion Therapeutics (ESPR) United States $0.362B 0.00
Bioventus (BVS) United States $0.340B 0.00
Aquestive Therapeutics (AQST) United States $0.321B 0.00
Fractyl Health (GUTS) United States $0.313B 0.00
Lyra Therapeutics (LYRA) United States $0.311B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.285B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.284B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Nanobiotix S.A (NBTX) France $0.270B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Black Diamond Therapeutics (BDTX) United States $0.260B 0.00
Adherex Technologies (FENC) United States $0.254B 0.00
Metagenomi (MGX) United States $0.250B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Acrivon Therapeutics (ACRV) United States $0.215B 0.00
Foghorn Therapeutics (FHTX) United States $0.215B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.211B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.198B 0.00
Century Therapeutics (IPSC) United States $0.198B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Galectin Therapeutics (GALT) United States $0.189B 0.00
Telomir Pharmaceuticals (TELO) United States $0.166B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
MediWound (MDWD) Israel $0.150B 0.00
Incannex Healthcare (IXHL) Australia $0.149B 0.00
CytoDyn (CYDY) United States $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.144B 0.00
Elite Pharmaceuticals (ELTP) United States $0.136B 12.72
VAXART, INC (VXRT) United States $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.83
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
Relmada Therapeutics (RLMD) United States $0.117B 0.00
OptiNose (OPTN) United States $0.116B 0.00
GlycoMimetics (GLYC) United States $0.116B 0.00
Inotiv (NOTV) United States $0.114B 0.00
FibroGen (FGEN) United States $0.113B 0.00
Eliem Therapeutics (ELYM) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.089B 0.00
ProPhase Labs (PRPH) United States $0.088B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.66
Marinus Pharmaceuticals (MRNS) United States $0.081B 0.00
Carisma Therapeutics (CARM) United States $0.078B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.81
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
Nutriband (NTRB) United States $0.028B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
MEI Pharma (MEIP) United States $0.022B 1.13
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
Addex Therapeutics (ADXN) Switzerland $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Cosmos Health (COSM) Greece $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.81